Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Apatinib With Postoperative Adjuvant Chemotherapy for Operable Colorectal Cancer

NCT03228043 is registered in ClinicalTrials.gov with Nanchong Central Hospital as lead sponsor.

NCT NCT03228043
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03228043 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Apatinib With Postoperative Adjuvant Chemotherapy for Operable Colorectal Cancer
Lead sponsor
Nanchong Central Hospital
Phase
Not applicable
Overall status
Withdrawn
Start date
March 1, 2020
Completion date
March 1, 2023
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adjuvant chemotherapy, apatinib, colorectal cancer, outcome, fatal, surgery